scholarly journals Medicare Prescription Drug Plan Enrollees Report Less Positive Experiences Than Their Medicare Advantage Counterparts

2016 ◽  
Vol 35 (3) ◽  
pp. 456-463 ◽  
Author(s):  
Marc N. Elliott ◽  
Bruce E. Landon ◽  
Alan M. Zaslavsky ◽  
Carol Edwards ◽  
Nathan Orr ◽  
...  
Keyword(s):  
Prescription Drug ◽  
Medicare Advantage ◽  
Drug Plan ◽  
Prescription Drug Plan ◽  
Positive Experiences

The Impact of Opioid Safety Edits on Opioid Utilization

2021 ◽  
Vol 36 (9) ◽  
pp. 433-438
Author(s):  
Tiffany Del Rosario ◽  
Molly Colombo ◽  
Marisa Brailsford ◽  
Sharon Jhawar ◽  
Romilla Batra
Keyword(s):  
Prescription Drug ◽  
Health Plan ◽  
Care Coordination ◽  
Retrospective Review ◽  
Medicare Advantage ◽  
Drug Plan ◽  
Prescription Drug Plan ◽  
Action Network ◽  
The Impact

Objective To evaluate the impact of opioid safety edits on opioid utilization. Design Retrospective review. Setting Senior Care Action Network (SCAN) Health Plan, a Medicare Advantage Prescription Drug Plan. Patients, Participants The opioid safety edits reviewed included edits for the following: initial opioid fill more than 7 days’ supply (DS), cumulative opioid doses 90 or greater and 240 or greater morphine milligram equivalent (MME), concurrent opioid and benzodiazepine (COB) use. Members with prescription drug claims meeting these criteria pre- and postedit implementation and those with prescription drug claim rejections resulting from the edits were included in the review. Results 15,232 members experienced claim rejections resulting from the edits. Comparison of utilization pre and postedit implementation revealed the following results (P < 0.001): 41% decrease in the proportion of members with an initial opioid fill for more than 7 DS; 18% decrease in the proportion of members on opioid doses 90 MME or more; 26% decrease in the proportion of members on opioid doses 240 MME or more; 18% decrease in the proportion of members with COB. Conclusion Opioid safety edits are an effective way to combat overuse and misuse. They serve as a means for increasing collaboration between plans, prescribers, pharmacists, and members which improves care coordination, reduces adverse risks, and helps keep members safe.

scholarly journals Falling into the Coverage Gap: Part D Drug Costs and Adherence for Medicare Advantage Prescription Drug Plan Beneficiaries with Diabetes

2010 ◽  
Vol 45 (2) ◽  
pp. 355-375 ◽  
Author(s):  
Vicki Fung ◽  
Carol M. Mangione ◽  
Jie Huang ◽  
Norman Turk ◽  
Elaine S. Quiter ◽  
...  
Keyword(s):  
Prescription Drug ◽  
Drug Costs ◽  
Medicare Advantage ◽  
Part D ◽  
Drug Plan ◽  
Coverage Gap ◽  
Prescription Drug Plan

scholarly journals Psychometric evaluation of the Medicare Advantage and prescription drug plan disenrollment reasons survey

2019 ◽  
Author(s):  
Steven C. Martino ◽  
Marc N. Elliott ◽  
Alan M. Zaslavsky ◽  
Nate Orr ◽  
Andy Bogart ◽  
...  
Keyword(s):  
Prescription Drug ◽  
Psychometric Evaluation ◽  
Medicare Advantage ◽  
Drug Plan ◽  
Prescription Drug Plan

scholarly journals PMH42 Utilization of Paliperidone Long-Acting Injection among Medicare Advantage and Medicare Prescription Drug Plan Members

2012 ◽  
Vol 15 (4) ◽  
pp. A89
Author(s):  
B. Suehs ◽  
Y. Li ◽  
A. Howe ◽  
D. Doshi ◽  
M. Pasquale ◽  
...  
Keyword(s):  
Prescription Drug ◽  
Medicare Advantage ◽  
Drug Plan ◽  
Prescription Drug Plan ◽  
Long Acting
Sign in / Sign up

Export Citation Format

Share Document